Catawba Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Catawba Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$200K	Buy	+967	New	+$205K	0.05%	206
2017 Q4	–	Sell	-2,602	Closed	-$492K	–	224
2017 Q3	$492K	Sell	2,602 -470	-15%	-$85.1K	0.11%	145
2017 Q2	$536K	Buy	3,072 +230	+8%	+$38.6K	0.12%	146
2017 Q1	$437K	Buy	2,842 +435	+18%	+$66.5K	0.1%	167
2016 Q4	$340K	Buy	2,407 +130	+6%	+$19.2K	0.08%	186
2016 Q3	$362K	Buy	2,277 +635	+39%	+$97.9K	0.09%	176
2016 Q2	$243K	Buy	1,642 +140	+9%	+$20.7K	0.06%	206
2016 Q1	$213K	Buy	+1,502	New	+$201K	0.05%	209

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Catawba Capital Management's TMO Position: Q2 2018 in Review

Catawba Capital Management opened a new position in Thermo Fisher Scientific (TMO) in Q2 2018: 967 shares worth $200K. The stake represents 0.05% of the portfolio and ranks #206 among its holdings. This is a return to the name: Catawba Capital Management previously reported a position in TMO as recently as Q3 2017.

Catawba Capital Management first reported a position in TMO in Q1 2016 and has held it in 8 quarters since. The position peaked at $536K in Q2 2017. 1,322 funds tracked by Wall St. Rank hold TMO as of Q2 2018.

Catawba Capital Management held 967 shares of Thermo Fisher Scientific worth $200K as of Q2 2018.
Thermo Fisher Scientific was a new Catawba Capital Management position in Q2 2018.
Thermo Fisher Scientific made up 0.05% of Catawba Capital Management's portfolio in Q2 2018, its #206 holding.
Catawba Capital Management first reported a position in Thermo Fisher Scientific in Q1 2016 and has held it in 8 quarters since.
Catawba Capital Management's Thermo Fisher Scientific position peaked at $536K in Q2 2017.
1,322 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2018.

Based on Catawba Capital Management's 13F filing for Q2 2018, filed 11 Jul 2018.